The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global PNH and aHUS Market Research Report 2025
Synopsis
PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death.
The global PNH and aHUS market was valued at US$ 5151.2 million in 2023 and is anticipated to reach US$ 7993.1 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
United States is the largest consumption place, with a consumption market share nearly 52.1% in 2019. Following United States, Europe is the second largest consumption place with the consumption market share of 26.2%.
This report aims to provide a comprehensive presentation of the global market for PNH and aHUS, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PNH and aHUS.
Report Scope
The PNH and aHUS market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PNH and aHUS market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PNH and aHUS companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alexion Pharmaceuticals
Alnylam Pharmaceuticals
Omeros Corporation
Segment by Type
Soliris
Ultomiris
Segment by Application
PNH
aHUS
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PNH and aHUS companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death.
The global PNH and aHUS market was valued at US$ 5151.2 million in 2023 and is anticipated to reach US$ 7993.1 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
United States is the largest consumption place, with a consumption market share nearly 52.1% in 2019. Following United States, Europe is the second largest consumption place with the consumption market share of 26.2%.
This report aims to provide a comprehensive presentation of the global market for PNH and aHUS, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PNH and aHUS.
Report Scope
The PNH and aHUS market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PNH and aHUS market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PNH and aHUS companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alexion Pharmaceuticals
Alnylam Pharmaceuticals
Omeros Corporation
Segment by Type
Soliris
Ultomiris
Segment by Application
PNH
aHUS
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PNH and aHUS companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PNH and aHUS Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Soliris
1.2.3 Ultomiris
1.3 Market by Application
1.3.1 Global PNH and aHUS Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 PNH
1.3.3 aHUS
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global PNH and aHUS Market Perspective (2019-2030)
2.2 PNH and aHUS Growth Trends by Region
2.2.1 Global PNH and aHUS Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 PNH and aHUS Historic Market Size by Region (2019-2024)
2.2.3 PNH and aHUS Forecasted Market Size by Region (2025-2030)
2.3 PNH and aHUS Market Dynamics
2.3.1 PNH and aHUS Industry Trends
2.3.2 PNH and aHUS Market Drivers
2.3.3 PNH and aHUS Market Challenges
2.3.4 PNH and aHUS Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PNH and aHUS Players by Revenue
3.1.1 Global Top PNH and aHUS Players by Revenue (2019-2024)
3.1.2 Global PNH and aHUS Revenue Market Share by Players (2019-2024)
3.2 Global PNH and aHUS Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PNH and aHUS Revenue
3.4 Global PNH and aHUS Market Concentration Ratio
3.4.1 Global PNH and aHUS Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PNH and aHUS Revenue in 2023
3.5 PNH and aHUS Key Players Head office and Area Served
3.6 Key Players PNH and aHUS Product Solution and Service
3.7 Date of Enter into PNH and aHUS Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PNH and aHUS Breakdown Data by Type
4.1 Global PNH and aHUS Historic Market Size by Type (2019-2024)
4.2 Global PNH and aHUS Forecasted Market Size by Type (2025-2030)
5 PNH and aHUS Breakdown Data by Application
5.1 Global PNH and aHUS Historic Market Size by Application (2019-2024)
5.2 Global PNH and aHUS Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America PNH and aHUS Market Size (2019-2030)
6.2 North America PNH and aHUS Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America PNH and aHUS Market Size by Country (2019-2024)
6.4 North America PNH and aHUS Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PNH and aHUS Market Size (2019-2030)
7.2 Europe PNH and aHUS Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe PNH and aHUS Market Size by Country (2019-2024)
7.4 Europe PNH and aHUS Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PNH and aHUS Market Size (2019-2030)
8.2 Asia-Pacific PNH and aHUS Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific PNH and aHUS Market Size by Region (2019-2024)
8.4 Asia-Pacific PNH and aHUS Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PNH and aHUS Market Size (2019-2030)
9.2 Latin America PNH and aHUS Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America PNH and aHUS Market Size by Country (2019-2024)
9.4 Latin America PNH and aHUS Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PNH and aHUS Market Size (2019-2030)
10.2 Middle East & Africa PNH and aHUS Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa PNH and aHUS Market Size by Country (2019-2024)
10.4 Middle East & Africa PNH and aHUS Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alexion Pharmaceuticals
11.1.1 Alexion Pharmaceuticals Company Detail
11.1.2 Alexion Pharmaceuticals Business Overview
11.1.3 Alexion Pharmaceuticals PNH and aHUS Introduction
11.1.4 Alexion Pharmaceuticals Revenue in PNH and aHUS Business (2019-2024)
11.1.5 Alexion Pharmaceuticals Recent Development
11.2 Alnylam Pharmaceuticals
11.2.1 Alnylam Pharmaceuticals Company Detail
11.2.2 Alnylam Pharmaceuticals Business Overview
11.2.3 Alnylam Pharmaceuticals PNH and aHUS Introduction
11.2.4 Alnylam Pharmaceuticals Revenue in PNH and aHUS Business (2019-2024)
11.2.5 Alnylam Pharmaceuticals Recent Development
11.3 Omeros Corporation
11.3.1 Omeros Corporation Company Detail
11.3.2 Omeros Corporation Business Overview
11.3.3 Omeros Corporation PNH and aHUS Introduction
11.3.4 Omeros Corporation Revenue in PNH and aHUS Business (2019-2024)
11.3.5 Omeros Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
